Időskori makuladegeneráció: vizsgálatok itt: Ausztria
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Where
- Innsbruck, Linz, Mistelbach
- Életkor
- 50 év and over
- People
- 250 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00 - 3. fázisTaking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Graz, Vienna
- Életkor
- 50 év to 85 év
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - 3. fázisTaking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Graz, Innsbruck, Linz, Mistelbach, Salzburg
- Életkor
- 50 év and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - 3. fázisTaking peopleExtension Study for the Port Delivery System With Ranibizumab (Portal)
- Where
- Graz, Vienna
- Életkor
- 50 év and over
- People
- 1000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00 - 2/3. fázisTaking peopleA clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
- Where
- Graz, Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524894-17-00 · EU 2025-524894-17-00 - 2. fázisTaking peopleStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Where
- Linz, Vienna
- Életkor
- 55 év and over
- People
- 324 worldwide
- Run by
- ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00 - 2. fázisTaking peoplePhase 2 Study of ADX-038 in Participants With Geographic Atrophy
- Where
- Graz, Innsbruck, Vienna
- Életkor
- 60 év and over
- People
- 240 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00 - No phaseTaking peopleStem Cell Ophthalmology Treatment Study II
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- MD Stem Cells
See details and how to joinNCT03011541 - 4. fázisTaking peopleTwo initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD
- Where
- Graz
- Életkor
- 18 év and over
- People
- 50
- Run by
- Medical University Of Graz
See details and how to join2025-523478-17-00 · EU 2025-523478-17-00 - No phaseTaking peopleRetinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 35
- Run by
- Medical University of Vienna
See details and how to joinNCT03921931 - No phaseTaking peoplePersonalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
- Where
- Vienna
- Életkor
- 55 év to 99 év
- People
- 200 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06351657 - No phaseTaking peoplePersonalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
- Where
- Vienna
- Életkor
- 55 év to 99 év
- People
- 500 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06351670 - No phaseTaking peopleAflibercept in Recurrent or Persistent CNV
- Where
- Vienna
- Életkor
- 50 év and over
- People
- 80
- Run by
- Medical University of Vienna
See details and how to joinNCT02669953 - 4. fázisTaking peopleTreatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
- Where
- Vienna
- Életkor
- 50 év to 100 év
- People
- 290
- Run by
- Medical University of Vienna
See details and how to joinNCT05093374 - No phaseCsak meghívásosDeciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)
- Where
- Vienna
- People
- 300 worldwide
- Run by
- University of Southampton
See details and how to joinNCT06682455 - No phaseTaking peopleDiagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
- Where
- Linz
- Életkor
- 5 év to 110 év
- People
- 500
- Run by
- Johannes Kepler University of Linz
See details and how to joinNCT06074731